Summary
Machine-generated summaryThis public tender from Romania concerns the procurement of medicines for the digestive tract and metabolism, specifically the drug Olipudase Alfa. The purchase is part of the National Rare Diseases Program for DSMA. The buyer is a Romanian public health authority managing this national program. The place of delivery is Romania. Small businesses interested in supplying this medication should consult the official tender documents for complete details, deadlines, and participation requirements.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profileRecent awards
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Status: Now marked as Closed
- Estimated value: Set to €2,327,222
- Submission deadline: Moved 1 day EARLIER: now July 24, 2026, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
- Estimated value: Set to €12,220,243
Follow this tender and we email you the moment it changes. Create account
Similar tenders
1
day left
€169,005
est. value
1
day left
€616,850
est. value
1
day left
€172,767,852
est. value
1
day left
€2,071,619
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,101,350
- Buyer track record on Aperlena
- 12 notices tracked · 4 awarded
- €4,447,038 in awarded contracts
Never miss a tender like this
320 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alert